Title : Ado-trastuzumab Emtansine (T-DM1): an antibody-drug conjugate (ADC) for HER2-positive breast cancer.

Pub. Date : 2014 Aug 28

PMID : 24967516






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Ado-trastuzumab Emtansine (T-DM1): an antibody-drug conjugate (ADC) for HER2-positive breast cancer. t-dm1 immunoglobulin heavy diversity 1-7 Homo sapiens
2 Ado-trastuzumab emtansine (T-DM1) is an antibody-drug conjugate that combines the antitumor properties of the humanized anti-human epidermal growth factor receptor 2 (HER2) antibody, trastuzumab, with the maytansinoid, DM1, a potent microtubule-disrupting agent, joined by a stable linker. t-dm1 immunoglobulin heavy diversity 1-7 Homo sapiens
3 Ado-trastuzumab emtansine (T-DM1) is an antibody-drug conjugate that combines the antitumor properties of the humanized anti-human epidermal growth factor receptor 2 (HER2) antibody, trastuzumab, with the maytansinoid, DM1, a potent microtubule-disrupting agent, joined by a stable linker. t-dm1 immunoglobulin heavy diversity 1-7 Homo sapiens